Clinical Trial

ALPs Single ChambEr New Device

Study acronym: ASCEND
Not Yet Recruiting
View on ClinicalTrials.gov →
Summary
Prospective, non-randomized, multi-center, international study designed to evaluate the initial safety and performance of the ALPS leadless pacemaker when used in patients with bradycardia.
Trial Details
NCT Number NCT07461935
Lead Sponsor Cairdac SA
Conditions Bradycardia, Brady-tachy Syndrome, AV Block, Atrial Fibrillation (AF)
Enrollment 10 participants
Start Date 2026-06
Primary Completion 2027-03 (estimated)
Study Completion 2028-12 (estimated)
Updated on ClinicalTrials.gov 2026-03-10